A Scale to Assess Activities of Daily Living in Pantothenate Kinase-Associated Neurodegeneration.
Randall D MarshallAbigail CollinsMaria L EscolarH A JinnahFlorentine RadelfahrMichael C KruerAleksandar VidenovicAmy Robichaux-ViehoeverLaura SwettDennis A RevickiRandall H BenderWilliam R LenderkingPublished in: Movement disorders clinical practice (2019)
The PKAN-ADL scale demonstrated acceptable content validity, with evidence of construct validity and excellent reliability. Overall results support the use of the PKAN-ADL scale in clinical trials.